
Sunday, December 22, 2024 11:14:42 AM
And to start it off I’m taking the family to Amsterdam and Bruges for the holidays. Beautiful, vibrant cities. Incredible lights and landscapes. And an industrious, open minded people that understand capitalism and innovation. From The Dutch East India Company, a company that once had the highest valuation is the history of capitalism, to today’s innovative ASML, a company critical to the whole semiconductor industry, this region, the Low Countries, has been a vanguard of progress.
Since the nadir of the Dutch Hunger Winter and the kick start of a new era from Operation Chowhound and Operation Manna, this region and its people understand what it takes to succeed. And I might add you have a gracious and intelligent Queen that makes Lady Di look like a wallflower. No insult intended to the memory of Di.
So when intelligent investors from this region believe in a company and its technology then I’m listening.

Recent LWLG News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/02/2025 08:41:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/02/2025 08:39:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/02/2025 08:32:46 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 06/20/2025 08:54:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/20/2025 08:17:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/16/2025 08:11:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2025 09:02:04 PM
- Form DEFR14A - Revised definitive proxy soliciting materials • Edgar (US Regulatory) • 04/30/2025 08:05:23 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/28/2025 09:10:02 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/28/2025 09:19:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/21/2025 09:11:35 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/21/2025 09:08:27 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/18/2025 09:03:04 PM
- Lightwave Logic to Host Annual Meeting of Shareholders on May 15, 2025 • PR Newswire (US) • 03/17/2025 12:30:00 PM
- Lightwave Logic to Attend the 37th Annual ROTH Conference • PR Newswire (US) • 03/11/2025 12:30:00 PM
- Lightwave Logic and Polariton Technologies Expand Technical Partnership to Accelerate Introduction of 400Gb/s per lane and beyond for AI and Datacenter Optical Links • PR Newswire (US) • 03/10/2025 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2025 10:41:24 PM
- Lightwave Logic to Host Special Call on March 13, 2025 • PR Newswire (US) • 03/03/2025 09:01:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2025 07:47:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2025 09:06:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2025 09:37:05 PM
- Lightwave Logic to Attend the 2025 SPIE Photonics West Conference • PR Newswire (US) • 01/27/2025 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2025 09:04:19 PM
- Lightwave Logic Director Frederick Leonberger to Retire from Board of Directors and Transition to Company's Advisory Board • PR Newswire (US) • 01/03/2025 01:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2025 10:02:39 PM
FEATURED Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • Jul 9, 2025 9:15 AM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs • CLDI • Jul 7, 2025 9:00 AM